Long‐term Results Of Cytoreductive Surgery For Advanced And Recurrent Epithelial Ovarian Cancers And Papillary Serous Carcinoma Of The Peritoneum
M. Look, D. Chang, P. Sugarbaker
Published 2003 · Medicine
Download PDFAnalyze on Scholarcy
The aim of this study was to review the long-term results of cytoreductive surgery in the treatment of advanced primary and recurrent epithelial ovarian cancers and papillary serous carcinoma of the peritoneum. Our goal was to identify clinical factors by which to select patients likely to benefit from a comprehensive management plan. Clinical data of 28 females who underwent surgery were retrieved from a prospective database. Major cytoreductive procedures were possible in 25 patients. Heated intraoperative or early postoperative intraperitoneal chemotherapy was also used where appropriate. The median follow-up after cytoreduction was 26.9 months. The overall median survival after cytoreduction was 45.8 months. The prognostic indicators associated with a statistically significant impact on survival were the Prior Surgery Score (P < 0.001), the Completeness of Cytoreduction Score (P = 0.037) and response to chemotherapy prior to surgery (P = 0.012). Our findings suggest that cytoreductive surgery can be effective when combined with perioperative intraperitoneal chemotherapy. Results can be improved by excluding cases where completeness of cytoreduction seems unlikely. Extensive prior surgery without the protection of adjunctive intraperitoneal chemotherapy is associated with a poor prognosis. This may be due to disruption of anatomic planes leading to deep abdominal and pelvic dissemination intractable to further treatment.
This paper references
Papillary serous carcinoma of the peritoneum. A review of 33 cases treated with platin‐based chemotherapy
D. Ransom (1990)
Cytoreductive surgery for stage IV epithelial ovarian cancer.
R. Zang (1999)
Intervention debulking surgery in advanced epithelial ovarian cancer
C. Redman (1994)
Review of a personal experience in the management of carcinomatosis and sarcomatosis.
P. Sugarbaker (2001)
Ovarian cancer: Age contrasts in incidence, histology, disease stage at diagnosis, and mortality
R. Yancik (1993)
Ovarian and endometrial cancers.
J. Mant (1994)
Ovarian and endometrial cancers. Cancer Survey Trends Cancer Incidence Mortality 1994;9:287—307
Mant JWF (1994)
Clinical Gynaecologic Oncology
R. Hunter (1981)
Neoadjuvant chemotherapy and interval debulking for advanced epithelial ovarian cancer.
J. H. Jacob (1991)
Interval debulking surgery in advanced epithelial ovarian cancer.
S. Pecorelli (2002)
Impact of secondary cytoreductive surgery on survival of patients with advanced epithelial ovarian cancer.
R. Zang (2000)
Long term survival by cytoreductive surgery to less than 1 cm, induction weekly cisplatin and monthly cisplatin, doxorubicin, and cyclophosphaide therapy in advanced ovarian adenocarcinoma
T. Baker (1994)
The effect of debulking surgery after induction chemotherapy on the prognosis in advanced epithelial ovarian cancer. Gynecological Cancer Cooperative Group of the European Organization for Research and Treatment of Cancer.
M. V. D. van der Burg (1995)
THE EFFECT OF DEBULKING SURGERY AFTER INDUCTION CHEMOTHERAPY ON THE PROGNOSIS IN ADVANCED EPITHELIAL OVARIAN CANCER
Intraperitoneal chemotherapy and cytoreductive surgery for the prevention and treatment of peritoneal carcinomatosis and sarcomatosis.
P. Sugarbaker (1998)
Peritoneal carcinomatosis. features of dissemination
M Deraco (1999)
Current methodologies for clinical assessment of patients with peritoneal carcinomatosis
P Jacquet (1996)
Management of Peritoneal Surface Malignancy Using Intraperitoneal Chemotherapy and Cytoreductive Surgery. A Manual for Physicians and Nurses
PH Sugarbaker (1998)
Curative treatment of peritoneal carcinomatosis arising from colorectal cancer by complete resection and intraperitoneal chemotherapy
D. Elias (2001)
Cytoreductive surgery in ovarian carcinoma patients with a documented previously complete surgical response.
L. Vaccarello (1995)
Cytoreductive surgery for patients with stage IV epithelial ovarian cancer
RY Zang (1999)
The natural history and treatment of ovarian cancer.
D. Longo (1981)
Papillary serous adenocarcinoma of the peritoneum
DT Ransom (1990)
Title Pages / Contents
A. L. Barlow (2002)
The role of secondary cytoreductive surgery in the treatment of patients with recurrent epithelial ovarian carcinoma
S. Eisenkop (2000)
This paper is referenced by
Cytoreductive surgery and modified heated intraoperative intraperitoneal chemotherapy (HIPEC) for advanced and recurrent ovarian cancer -- 12-year single center experience.
M. Pavlov (2009)
A systematic review on the efficacy of cytoreductive surgery combined with perioperative intraperitoneal chemotherapy for diffuse malignancy peritoneal mesothelioma.
T. Yan (2007)
Preoperative Assessment of Cancer Patients with Peritoneal Metastases for Complete Cytoreduction
P. Sugarbaker (2016)
A systematic review on the efficacy of cytoreductive surgery combined with perioperative intraperitoneal chemotherapy for diffuse malignancy peritoneal mesothelioma
T. Yan (2007)
Extra-peritoneal hysteroannessiectomy with eventual concomitant en bloc rectal resection and cytoreductive surgery in epithelial ovarian cancer (and other peritoneal surface malignancies): technical details
Luigi Frigerio (2017)
Current status and future strategies of cytoreductive surgery plus intraperitoneal hyperthermic chemotherapy for peritoneal carcinomatosis.
Hassan-Alaa-Hammed Al-Shammaa (2008)
Abdominal Advanced Oncologic Surgery
Enrico Maria Pasqual (2012)
La chimiothérapie intrapéritonéale avec hyperthermie
O. Gléhen (2006)
Educational Review Intraperitoneal Hyperthermic Chemotherapy for Peritoneal Surface Malignancy: Current Status and Future Directions
J. Stewart (2005)
Primäre und sekundäre peritoneale Tumoren
P. Piso (2008)
Cytoreductive surgery for recurrent ovarian cancer: a meta-analysis.
R. Bristow (2009)
Cytoreductive Surgery and Perioperative Intraperitoneal Chemotherapy in Recurrent Ovarian Cancer
Antonios-Apostolos K Tentes (2010)
Consensus statement on the loco regional treatment of colorectal cancer with peritoneal dissemination.
J. Esquivel (2008)
Intraperitoneal cancer therapy
C. Helm (2007)
Cytoreductive surgery and intraperitoneal chemotherapy for treatment of peritoneal carcinomatosis from colorectal origin
F. Losa (2013)
Role of cytoreductive surgery in recurrent ovarian cancer
A. Fagotti (2010)
Cytoreductive surgery and perioperative intraperitoneal chemotherapy for pseudomyxoma peritonei from appendiceal mucinous neoplasms
T. Yan (2006)
CHIP et cancer de l’ovaire : en finir avec les préjugés
Naoual Bakrin (2012)
"METÁSTASIS PERITONEAL DE CÁNCER GASTROINTESTINAL: BREVE HISTORIA"
Paul H Sugarbaker (2014)
Current status and future directions of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in the treatment of ovarian cancer.
C. William Helm (2012)
Other primary peritoneal surface malignancies
P. Sammartino (2015)
Oncologic outcomes and morbidity following heated intraperitoneal chemotherapy at cytoreductive surgery for primary epithelial ovarian cancer: A systematic review and meta-analysis.
Geneviève Bouchard-Fortier (2020)
Surgical and Chemotherapy Treatment Outcomes of Goblet Cell Carcinoid: A Tertiary Cancer Center Experience
T. H. Pham (2006)
Hyperthermic intraperitoneal chemotherapy with and without cytoreductive surgery for epithelial ovarian cancer.
C. Helm (2008)
Primary peritoneal adenocarcinoma causes pleural effusion
M. Shameem (2010)
[HIPEC and ovarian carcinoma: base judgment on evidence].
Naoual Bakrin (2012)
Hyperthermic intraperitoneal chemotherapy ( HIPEC ) in optimally cytoreduced peritoneal carcinomatosis of gynecology origin : Does it provide survival advantage ?
E. Bree (2010)
Combined Cytoreductive Surgery and Perioperative Intraperitoneal Chemotherapy for the Treatment of Advanced Ovarian Cancer
A. Tentes (2012)
Secondary cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for recurrent epithelial ovarian cancer: a multi‐institutional study
M. Deraco (2012)
Protective effect of intra-peritoneal epinephrine on postoperative renal function after cisplatin-based intra-peritoneal intra-operative chemotherapy.
S. Pili-Floury (2011)
Update on the Treatment of Recurrent Ovarian Cancer
G. Eltabbakh (2006)
Cytoreductive surgery for peritoneal malignancies--development of standards of care for the community.
J. Esquivel (2007)See more